218 related articles for article (PubMed ID: 30972901)
21. [Standard protocol of ALK fusion gene assessment by fluorescent in situ hybridization in non-small cell lung cancer].
Guo L; Zheng S; Xie YQ
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):530-3. PubMed ID: 24246918
[TBL] [Abstract][Full Text] [Related]
22. Development of a novel ALK rearrangement screening test for non-small cell lung cancers.
Chen YL; Chen WL; Cheng YC; Lin MC; Yang SC; Tsai HW; Lin CC; Su WC; Chow NH; Ho CL
PLoS One; 2021; 16(9):e0257152. PubMed ID: 34559836
[TBL] [Abstract][Full Text] [Related]
23. ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Dacic S; Villaruz LC; Abberbock S; Mahaffey A; Incharoen P; Nikiforova MN
Oncotarget; 2016 Dec; 7(50):82943-82952. PubMed ID: 27769042
[TBL] [Abstract][Full Text] [Related]
24. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
[TBL] [Abstract][Full Text] [Related]
26. KIF5B-RET Fusion gene may coincide oncogenic mutations of EGFR or KRAS gene in lung adenocarcinomas.
Kim JO; Lee J; Shin JY; Oh JE; Jung CK; Park JK; Sung SW; Bae SJ; Min HJ; Kim D; Park JY; Kang JH
Diagn Pathol; 2015 Aug; 10():143. PubMed ID: 26268359
[TBL] [Abstract][Full Text] [Related]
27. Targeted RNA-sequencing assays: a step forward compared to FISH and IHC techniques?
Tachon G; Cortes U; Richard S; Martin S; Milin S; Evrard C; Lamour C; Karayan-Tapon L
Cancer Med; 2019 Dec; 8(18):7556-7566. PubMed ID: 31651105
[TBL] [Abstract][Full Text] [Related]
28. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
[TBL] [Abstract][Full Text] [Related]
29. KLC1-ALK: a novel fusion in lung cancer identified using a formalin-fixed paraffin-embedded tissue only.
Togashi Y; Soda M; Sakata S; Sugawara E; Hatano S; Asaka R; Nakajima T; Mano H; Takeuchi K
PLoS One; 2012; 7(2):e31323. PubMed ID: 22347464
[TBL] [Abstract][Full Text] [Related]
30. CUX1-ALK, a Novel ALK Rearrangement That Responds to Crizotinib in Non-Small Cell Lung Cancer.
Zhang M; Wang Q; Ding Y; Wang G; Chu Y; He X; Wu X; Shao YW; Lu K
J Thorac Oncol; 2018 Nov; 13(11):1792-1797. PubMed ID: 30010043
[TBL] [Abstract][Full Text] [Related]
31. Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.
Ma D; Wang Z; Yang L; Mu X; Wang Y; Zhao X; Li J; Lin D
Oncotarget; 2016 Sep; 7(39):64410-64420. PubMed ID: 27418132
[TBL] [Abstract][Full Text] [Related]
32. 5'/ 3' imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer.
Tong Y; Zhao Z; Liu B; Bao A; Zheng H; Gu J; McGrath M; Xia Y; Tan B; Song C; Li Y
J Exp Clin Cancer Res; 2018 Mar; 37(1):68. PubMed ID: 29587818
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the effectiveness of RNA in-situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement.
Nakajima N; Yoshizawa A; Kondo K; Rokutan-Kurata M; Hirata M; Furuhata A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Fujimoto M; Date H; Haga H
Histopathology; 2017 Jul; 71(1):143-149. PubMed ID: 28231386
[TBL] [Abstract][Full Text] [Related]
34. Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas.
Wagner F; Streubel A; Roth A; Stephan-Falkenau S; Mairinger T
J Clin Pathol; 2014 May; 67(5):403-7. PubMed ID: 24293609
[TBL] [Abstract][Full Text] [Related]
35. Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).
Kotoula V; Bobos M; Vassilakopoulou M; Tsolaki E; Chrisafi S; Psyrri A; Lazaridis G; Papadopoulou K; Efstratiou I; Michail-Strantzia C; Debelenko LV; Kosmidis P; Fountzilas G
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):60-70. PubMed ID: 25153496
[TBL] [Abstract][Full Text] [Related]
36. TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC.
Robesova B; Bajerova M; Liskova K; Skrickova J; Tomiskova M; Pospisilova S; Mayer J; Dvorakova D
Lung Cancer; 2014 Jul; 85(1):25-30. PubMed ID: 24792336
[TBL] [Abstract][Full Text] [Related]
37. Using Disposable Membrane Cell Collector to Enrich Lung Adenocarcinoma Cells in Bloody Pleural Effusion for Anaplastic Lymphoma Kinase Fusion Gene Detection.
Guo X; Zhao J; Du Y; Liu Y; Ma Y; Wang R; Ji X; Wu J; Dong L
Acta Cytol; 2021; 65(3):235-241. PubMed ID: 33631757
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence in Situ Hybridization (FISH) for Detecting Anaplastic Lymphoma Kinase (
Tang Z; Wang L; Tang G; Medeiros LJ
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412611
[TBL] [Abstract][Full Text] [Related]
39. Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
Vendrell JA; Taviaux S; Béganton B; Godreuil S; Audran P; Grand D; Clermont E; Serre I; Szablewski V; Coopman P; Mazières J; Costes V; Pujol JL; Brousset P; Rouquette I; Solassol J
Sci Rep; 2017 Oct; 7(1):12510. PubMed ID: 28970558
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of EML4-ALK gene fusion mutation in patients
with non-small cell lung cancer].
Wang X; Chen W; Yu Y
Zhongguo Fei Ai Za Zhi; 2015 Feb; 18(2):80-4. PubMed ID: 25676400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
